VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2021

Feb 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2021-02-03

Reporting Person: Bozic Carmen (EVP and CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-03	Common Stock	A	10324	$0.00	Acquired	24315	Direct
2021-02-03	Common Stock	A	11627	$0.00	Acquired	35942	Direct

Footnotes

F1: Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021.

F2: Restricted stock unit award that vests in installments beginning on 02/17/2022.